Table 1.
Demographic and clinical data of the patient cohort.
| Clinical characteristics and laboratory data | All patients (n = 112) |
|---|---|
| Gender | |
| Male | 51 (45.54 %) |
| Female | 61 (54.46 %) |
| Age (y) | 55.8 ± 16.1 (12–89) |
| Male | 58.3 ± 16.2 (25–89) |
| Female | 53.7 ± 15.9 (12–86) |
| Inital symptoms | |
| Fever | 84 (75.0 %) |
| Low grade fever (37.3−38.0) | 46 (41.1 %) |
| Moderate grade fever (38.1−39.0) | 31 (27.6 %) |
| High grade fever (>39.0) | 7 (6.2 %) |
| Dry Cough | 48 (42.8 %) |
| Expectoration | 15 (13.3 %) |
| Throat pain | 4 (3.5 %) |
| Chest distress | 24 (21.4 %) |
| Dyspnea | 18 (16.1 %) |
| Fatigue | 38 (33.9 %) |
| Nausea and vomiting | 4 (3.5 %) |
| Abdominal pain and diarrhea | 14 (12.5 %) |
| Myalgia | 18 (16.1 %) |
| Headache | 8 (7.1 %) |
| Dizziness | 2 (1.7 %) |
| Palpitation | 2 (1.7 %) |
| Laboratory investigations | |
| White blood cell count, WBC (109/L) | 5.6 ± 2.9 (0.9–16.4) |
| Neutrophil count, N (109/L) | 4.2 ± 2.9 (0.4–15.7) |
| Neutrophil percentage (%) | 68.7 ± 14.6 (39.6–97.1) |
| Lymphocyte count, L (109/L) | 1.0 ± 0.5 (0.1–2.3) |
| Lymphocyte percentage (%) | 21.6 ± 12.0 (1.5–47.1) |
| Monocytes count, M (109/L) | 0.4 ± 0.2 (0.1–1.1) |
| Monocytes percentage (%) | 8.6 ± 4.2 (1.0–23.5) |
| Red blood cell count, RBC (1012/L) | 4.1 ± 0.5 (2.9–6.1) |
| Blood platelet, PLT (109/L) | 210.4 ± 91.1 (62.0–469.0) |
| Hemoglobin, HGB (g/L) | 130.0 ± 15.5 (78.8–184.0) |
| C-reactive protein, CRP (mg/L) | 51.5 ± 81.8 (0.2–646.0) |
| Erythrocyte sedimentation rate, ESR (mm/h) | 29.1 ± 25.6 (2.0–119.0) |
| Alanine aminotransferase, ALT (U/L) | 34.8 ± 31.6 (8.0–175.0) |
| Aspartate aminotransferase, AST (U/L) | 32.3 ± 18.5 (9.0–90.0) |
| Total bilirubin, TBIL (μmol/L) | 13.2 ± 6.3 (4.6–38.2) |
| Albumin, ALB (g/L) | 37.5 ± 6.5 (23.3–74.3) |
| Globulin, GLB (g/L) | 30.0 ± 4.3 (22.1–43.5) |
| Urea (mmol/L) | 4.8 ± 2.0 (1.4–14.3) |
| Creatinine, Crea (μmol/L) | 68.4 ± 19.2 (34.4–158.7) |
| Fasting blood glucose, FBG (mmol/L) | 6.8 ± 2.6 (3.7–16.8) |
| Lactate dehydrogenase, LDH (U/L) | 260.5 ± 175.7 (46.0–1305.0) |
| Creatine kinase, CK (U/L) | 119.4 ± 149.5 (1.7–882.0) |
| Creatine kinase isoenzyme MB, CK-MB (U/L) | 13.6 ± 6.6 (2.0–44.0) |
| lnterleukin-6, IL-6 (pg/mL) | 30.6 ± 50.4 (0.1–309.0) |
| Prothrombin time, PT (s) | 12.9 ± 1.9 (10.4–27.4) |
| D-dimer (ng/mL) | 2405.8 ± 7079.0 (33.0–43142.0) |
| The period between the onset of initial symptoms and the hospitalized (d) | 8.0 ± 5.2 (1–22) |
| The frequency of CT scans | |
| 1 scan | 13 (11.6 %) |
| 2 scans | 30 (26.8 %) |
| 3 scans | 31 (27.7 %) |
| 4 scans | 19 (16.9 %) |
| 5 scans | 12 (10.7 %) |
| 6 scans | 5 (4.5 %) |
| 7 scans | 0 (0%) |
| 8 scans | 2 (1.8 %) |
| Total number of CT scans | 348 |
| Average number of CT scans per person | 3.1 ± 1.4 (1–8) |